Multi-Omics Inflammatory Phenotype for ABPA Recurrence Risk Prediction

Clinical trial NCT07611838 · RECRUITING

Trial details

NCT number: NCT07611838
Sponsor: Qianfoshan Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Allergic Bronchopulmonary Aspergillosis (ABPA)Machine Learning Multi-omics Multicenter Study Relapse

Start date: 2021-01-01
Primary completion: 2028-12-31
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.